Akcea Therapeutics, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 08/31/2020   Download
SEC Document
SEC Filing

On August 30, 2020, the Company Board adopted an amendment to the Company’s Amended and Restated Bylaws, as amended (the “Bylaws”), which amendment took effect upon adoption by the Company Board. Specifically, Section 46 of the Bylaws (“Section 46”) was modified to provide that, unless the Company consents in writing to the selection of an alternative forum, the federal district courts located in Boston, Massachusetts, to the fullest extent permitted by law, will be the sole and exclusive forum for the resolution of any complaint asserting a cause of action against the Company arising under the United States federal securities laws. The amendment also provides that the Company shall be entitled to injunctive relief and specific performance to enforce the provisions of Section 46.